首頁 > 市場調查報告書 > 材料

殺蟲劑

市場調查報告書

商品編碼

1547530

全球異噁唑啉市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Isoxazoline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球異噁唑啉市場需求將從2023年的16億美元達到2032年近54.5億美元的市場規模，2024-2032年研究期間複合年成長率為14.55%。

異噁唑啉是一類五元雜環化合物，包含彼此鄰近的氧和氮各一個原子。它可以透過腈氧化物與烯烴的1,3-偶極環加成反應、2-異噁唑啉的N-甲基化反應以及硝酮和炔烴之間的環加成反應來製備。異噁唑啉有多種用途，其中許多具有生物活性。它們具有廣譜的殺蟲和殺蟎活性，可有效對抗跳蚤和蜱等許多獸醫寄生蟲。

市場動態

預計全球異噁唑啉市場在預測期內將以穩定的速度成長。對寵物的寄生蟲攻擊不斷增加、對異噁唑啉潛力的研究不斷深入以及寵物擁有量的增加是引導全球異噁唑啉市場的因素。由於具有殺蟲、抗菌、抗生素、抗腫瘤、抗真菌、抗結核、抗癌和致潰瘍等特性，異噁唑啉在藥物和治療學中的用途和探索正在不斷擴大。此外，異噁唑啉作為抗癌劑在藥物化學領域具有重要意義。然而，FDA 幾乎沒有收到關於異噁唑啉可能對狗和貓造成神經系統不良事件的警告，這限制了市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對異噁唑啉全球市場的每個細分市場進行了包容性評估。異噁唑啉產業的成長和趨勢為本研究提供了整體方法。

市場區隔

異噁唑啉市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

氟拉納
阿福奧拉納
薩羅拉納
洛蒂拉納

依寵物類型

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲異噁唑啉市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。異噁唑啉市場的主要參與者包括默克動物保健公司、Elanco 動物保健公司、勃林格殷格翰國際有限公司、碩騰公司等。發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：異噁唑啉公司的競爭格局

異噁唑啉市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck Animal Health Inc

公司概況
公司收入
產品
最新動態

Elanco Animal Health Incorporated

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Zoetis Inc. Etc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215055

The global demand for Isoxazoline Market is presumed to reach the market size of nearly USD 5.45 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 14.55% under the study period 2024-2032.

Isoxazoline is a class of five-membered heterocyclic compounds, comprising one atom each of oxygen and nitrogen, located adjacent to each other. It can be produced by the 1,3-dipolar cycloaddition of nitrile oxides with alkenes, 2-isoxazolines by N-methylation, and cycloaddition between a nitrone and an alkyne. Isoxazolines have a variety of uses, with many being biologically active. They exhibit a broad spectrum of insecticidal and acaricidal activity and are effective against many veterinary parasites such as fleas and ticks.

MARKET DYNAMICS

The global isoxazoline market is estimated to grow at a steady rate during the forecast period. Increasing parasite attacks on pets, advancing research on the potentials of isoxazoline, and rising pet ownership are factors steering the global isoxazoline market. Isoxazoline is finding its expanding use and exploration in pharmaceuticals and therapeutics due to the properties such as insecticidal, antibacterial, antibiotic, antitumor, antifungal, antituberculosis, anticancer, and ulcerogenic. In addition, Isoxazoline has gained much significance in the field of medicinal chemistry as an anticancer agent. However, few alerts were received from the FDA about isoxazoline's potential for neurologic adverse events in dogs and cats, restraining market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Isoxazoline. The growth and trends of Isoxazoline industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Isoxazoline market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Fluralaner
Afoxolaner
Sarolaner
Lotilaner

By Pet Type

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Isoxazoline market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Isoxazoline market include Merck Animal Health Inc, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Zoetis Inc. Etc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ISOXAZOLINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Pet Type
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Fluralaner Historic and Forecast Sales By Regions
5.4. Afoxolaner Historic and Forecast Sales By Regions
5.5. Sarolaner Historic and Forecast Sales By Regions
5.6. Lotilaner Historic and Forecast Sales By Regions

6. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PET TYPE

6.1. Overview By Pet Type
6.2. Historical and Forecast Data Analysis By Pet Type
6.3. Cat Historic and Forecast Sales By Regions
6.4. Dog Historic and Forecast Sales By Regions

7. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ISOXAZOLINE COMPANIES

8.1. Isoxazoline Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF ISOXAZOLINE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Merck Animal Health Inc
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Elanco Animal Health Incorporated
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boehringer Ingelheim International GmbH
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Zoetis Inc. Etc
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments